Stocktoria
DEXCOM INC DXCM
Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2005-04-14
DEXCOM INC statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Gross margin | 60.1% | 60.5% | 63.2% | 64.7% | 68.6% |
| Operating margin | 19.6% | 14.9% | 16.5% | 13.4% | 10.9% |
| Net margin | 17.9% | 14.3% | 14.9% | 11.7% | 8.9% |
| FCF margin | 23.1% | 15.6% | 14.1% | 10.5% | 2.2% |
| Return on assets | 13.2% | 8.9% | 8.6% | 6.3% | 4.4% |
| Return on equity | 30.5% | 27.4% | 26.2% | 16.0% | 10.6% |
| Current ratio | 1.88 | 1.47 | 2.84 | 1.99 | 5.11 |
| Revenue growth | 15.6% | 11.3% | 24.5% | 18.8% | 27.1% |
Source: SEC EDGAR filings · CIK 0001093557 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.